Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

prognosis

  • Open Access
    Over-expression of Anterior Gradient 3 Is Associated With Tumor Progression and Poor Survival in Gastric Cancer
    WAN-SIK LEE, SUN-YOUNG PARK, YOUNG-LAN PARK and YOUNG-EUN JOO
    In Vivo January 2023, 37 (1) 483-489; DOI: https://doi.org/10.21873/invivo.13103
  • Open Access
    Fc Receptor Expression as a Prognostic Factor in Patients With Non-small-cell Lung Cancer
    MIN HYE KIM, JEONG HEE LEE, JONG SIL LEE, DONG CHUL KIM, JUNG WOOK YANG, HYO JUNG AN, JI MIN NA, MEONG CHEOL SHIN and DAE HYUN SONG
    In Vivo November 2022, 36 (6) 2708-2713; DOI: https://doi.org/10.21873/invivo.13006
  • Open Access
    Clinicopathological and Prognostic Significance of Programmed Death Ligand-1 SP142 Expression in 132 Patients With Triple-negative Breast Cancer
    JINAH CHU, MIN-KYUNG YEO, SANG HWA LEE, MI YEON LEE, SEOUNG WAN CHAE, HYUN-SOO KIM and SUNG-IM DO
    In Vivo November 2022, 36 (6) 2890-2898; DOI: https://doi.org/10.21873/invivo.13030
  • Open Access
    Expression of ADAM12 in Gastric Cancer and its Relation to Tumor Cell Behavior and Prognosis
    MIN-WOO CHUNG, YOUNG-LAN PARK, SUN-YOUNG PARK and YOUNG-EUN JOO
    In Vivo September 2022, 36 (5) 2194-2204; DOI: https://doi.org/10.21873/invivo.12945
  • Open Access
    The Prognostic Significance of Preoperative Anemia in Gastric Cancer Patients
    TOMOHIRO KUNISHIGE, KAZUHIRO MIGITA, SOHEI MATSUMOTO, KOHEI WAKATSUKI, HIROSHI NAKADE, SATOKO AOKI, SHINTARO MIYAO, TAKANARI TATSUMI, AKINORI TSUJIMOTO and MASAYUKI SHO
    In Vivo September 2022, 36 (5) 2314-2322; DOI: https://doi.org/10.21873/invivo.12962
  • Open Access
    Impact of Subclassification of Serosal Invasion on the Survival of Patients With T4a Gastric Cancer
    KENJI NAKAMURA, KOHEI TAJIMA, KOHEI KANAMORI, KENTARO YATABE, MIKA OGIMI, TADASHI HIGUCHI, MIHO YAMAMOTO, HITOSHI HARA, AKIHITO KAZUNO, KAZUHITO NABESHIMA, EIJI NOMURA and KAZUO KOYANAGI
    In Vivo July 2022, 36 (4) 1923-1929; DOI: https://doi.org/10.21873/invivo.12913
  • Open Access
    Pre-treatment CRP and Albumin Determines Prognosis for Unresectable Advanced Oesophageal Cancer
    MAKOTO SOHDA, MAKOTO SAKAI, ARISA YAMAGUCHI, TAKAYOSHI WATANABE, NOBUHIRO NAKAZAWA, YASUNARI UBUKATA, KENGO KURIYAM, AKIHIKO SANO, TAKEHIKO YOKOBORI, HIROOMI OGAWA, KEN SHIRABE and HIROSHI SAEKI
    In Vivo July 2022, 36 (4) 1930-1936; DOI: https://doi.org/10.21873/invivo.12914
  • Open Access
    Role of MicroRNA-31 (miR-31) in Breast Carcinoma Diagnosis and Prognosis
    AMAL F. GHARIB, AMANY SALAH KHALIFA, EMAD MOHAMED EED, HAMSA JAMEEL BANJER, ASHJAN ALI SHAMI, AHMAD EL ASKARY and WAEL H. ELSAWY
    In Vivo May 2022, 36 (3) 1497-1502; DOI: https://doi.org/10.21873/invivo.12857
  • You have access
    Hypoxia-induced Maspin Expression Affects the Prognosis of Ovarian Clear Cell Carcinoma
    EUN JI LEE, SOO JIN PARK, CHEOL LEE, GA WON YIM, JAE WEON KIM and HEE SEUNG KIM
    In Vivo January 2022, 36 (1) 212-220; DOI: https://doi.org/10.21873/invivo.12693
  • You have access
    Changes in Chemotherapeutic Strategies and Their Prognostic Impact in Patients With Advanced Gastric Cancer
    TAKAAKI ARIGAMI, DAISUKE MATSUSHITA, KEISHI OKUBO, TAKAKO TANAKA, KEN SASAKI, YUSUKE TSURUDA, YOSHIAKI KITA, SHINICHIRO MORI, HIROSHI KURAHARA, YOSHIKAZU UENOSONO and TAKAO OHTSUKA
    In Vivo January 2022, 36 (1) 409-415; DOI: https://doi.org/10.21873/invivo.12718

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
In Vivo

© 2023 In Vivo

Powered by HighWire